UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2023-02-16 | Future report Set alerts | |
| Q3 2022 | 2022-10-27 | 4.68 | 4.68 |
| Q2 2022 | 2022-07-28 | 4.95 | 4.95 |
| Q1 2022 | 2022-04-28 | 6.11 | 6.11 |
| Q4 2021 | 2022-02-10 | 6.77 | 6.77 |
| Q3 2021 | 2021-10-28 | 6.82 | 6.82 |
| Q2 2021 | 2021-07-29 | 6.13 | 6.13 |
| Q1 2021 | 2021-04-29 | 8.79 | 8.79 |
| Q4 2020 | 2021-02-11 | 10.56 | 10.56 |
| Q3 2020 | 2020-10-27 | 8.41 | 8.41 |
| 2016-06-09 | Reiterated Rating | Credit Suisse | Outperform | $135.00 to $143.00 |
| 2016-06-09 | Reiterated Rating | Credit Suisse Group AG | Outperform | $135.00 to $143.00 |
| 2016-05-22 | Reiterated Rating | KeyBanc | Buy | $143.00 |
| 2016-05-22 | Reiterated Rating | KeyCorp | Buy | $143.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
| 2016-05-02 | Reiterated Rating | Morgan Stanley | Buy | |
| 2016-04-26 | Boost Price Target | Jefferies Group | Hold | $121.00 to $131.00 |
| 2016-04-26 | Boost Price Target | Canaccord Genuity | Buy | $135.00 to $140.00 |
| 2016-04-26 | Boost Price Target | Barclays | Overweight | $152.00 to $155.00 |
| 2016-04-26 | Boost Price Target | Mizuho | Neutral | $119.00 to $132.00 |
| 2016-04-26 | Boost Price Target | Barclays PLC | Overweight | $152.00 to $155.00 |
| 2016-03-23 | Boost Price Target | Goldman Sachs | $119.00 | |
| 2016-03-23 | Boost Price Target | Goldman Sachs Group Inc. | $119.00 | |
| 2016-03-15 | Initiated Coverage | Credit Suisse | Outperform | $133.00 |
| 2016-03-04 | Reiterated Rating | William Blair | Outperform | |
| 2016-02-23 | Lower Price Target | Deutsche Bank | Hold | $134.00 to $121.00 |
| 2016-02-23 | Lower Price Target | Jefferies Group | Hold | $134.00 to $121.00 |
| 2016-02-23 | Lower Price Target | Deutsche Bank AG | Hold | $134.00 to $121.00 |
| 2016-02-19 | Reiterated Rating | Canaccord Genuity | Buy | $145.00 to $135.00 |
| 2016-02-19 | Lower Price Target | RBC Capital | Sector Perform | $135.00 to $130.00 |
| 2016-02-19 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $135.00 to $130.00 |
| 2016-02-16 | Lower Price Target | SunTrust | Buy | $145.00 to $134.00 |
| 2016-02-16 | Lower Price Target | SunTrust Banks Inc. | Buy | $145.00 to $134.00 |
| 2016-02-04 | Lower Price Target | Raymond James | Outperform | $145.00 to $135.00 |
| 2016-02-04 | Lower Price Target | Raymond James Financial Inc. | Outperform | $145.00 to $135.00 |
| 2016-01-07 | Boost Price Target | Barclays | Overweight | $140.00 to $150.00 |
| 2015-12-22 | Lower Price Target | Goldman Sachs | Neutral | $126.00 to $125.00 |
| 2015-12-17 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-12-08 | Downgrade | Goldman Sachs | Buy to Neutral | $142.00 to $126.00 |
| 2015-10-27 | Reiterated Rating | Canaccord Genuity | Buy | $145.00 |
| 2015-10-26 | Reiterated Rating | William Blair | Buy | |
| 2015-08-03 | Reiterated Rating | Canaccord Genuity | Buy | $145.00 |
| 2015-07-29 | Reiterated Rating | Mizuho | Neutral | $127.00 to $130.00 |
| 2015-06-15 | Initiated Coverage | KeyBanc | Overweight | $143.00 |
| 2015-06-09 | Reiterated Rating | Jefferies Group | Hold | |
| 2015-04-28 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $141.00 to $144.00 |
| 2015-04-28 | Boost Price Target | Jefferies Group | Hold | $108.00 to $134.00 |
| 2015-04-28 | Reiterated Rating | William Blair | Outperform | |
| 2015-03-27 | Initiated Coverage | JMP Securities | Outperform | $165.00 |
| 2015-03-24 | Boost Price Target | Maxim Group | Buy | $141.00 to $160.00 |
| 2015-03-23 | Set Price Target | Cantor Fitzgerald | Buy | $115.00 |
| 2015-03-03 | Upgrade | Canaccord Genuity | Hold to Buy | $100.00 to $145.00 |
| 2015-03-02 | Initiated Coverage | Barclays | Overweight | $140.00 |
| 2015-02-26 | Initiated Coverage | Goldman Sachs | Conviction-Buy | $140.00 |
| 2015-02-23 | Initiated Coverage | Wells Fargo & Co. | Market Perform | |
| 2015-02-23 | Upgrade | Morgan Stanley | Underweight to Overweight | |
| 2015-02-23 | Upgrade | Piper Jaffray | Neutral to Overweight | $113.00 to $140.00 |
| 2015-02-23 | Boost Price Target | Mizuho | Buy | $110.00 to $127.00 |
| 2015-02-23 | Upgrade | Credit Suisse | Neutral to Outperform | $113.00 to $140.00 |
| 2015-02-23 | Initiated Coverage | Wells Fargo | Market Perform | |
| 2015-02-23 | Upgrade | Piper Jaffray Cos. | Neutral to Overweight | $113.00 to $140.00 |
| 2015-01-20 | Upgrade | Evercore ISI | Hold to Buy | $105.00 to $132.00 |
| 2015-01-12 | Upgrade | Robert W. Baird | Neutral to Outperform | $105.00 to $137.00 |
| 2015-01-08 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $119.00 to $130.00 |
| 2015-01-05 | Boost Price Target | Maxim Group | Buy | $130.00 to $141.00 |
| 2015-01-05 | Upgrade | Citigroup Inc. | Neutral to Buy | $114.00 to $132.00 |
| 2015-01-02 | Upgrade | Raymond James | Market Perform to Outperform | $107.90 to $130.00 |
| 2014-11-13 | Downgrade | Deutsche Bank | Buy to Hold | $120.00 to $115.00 |
| 2014-11-03 | Reiterated Rating | Deutsche Bank | Buy | $116.00 to $120.00 |
| 2014-10-29 | Reiterated Rating | FBR & Co. | Market Perform | $106.00 to $112.00 |
| 2014-10-29 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $95.00 to $119.00 |
| 2014-10-29 | Reiterated Rating | Citigroup Inc. | Neutral | $106.00 to $114.00 |
| 2014-10-29 | Reiterated Rating | FBR & Co | Market Perform | $106.00 to $112.00 |
| 2014-07-17 | Upgrade | William Blair | Market Perform to Outperform | |
| 2014-07-17 | Boost Price Target | Maxim Group | Buy | $110.00 to $120.00 |
| 2014-05-09 | Reiterated Rating | Cantor Fitzgerald | Buy | $105.00 to $115.00 |
| 2014-04-02 | Boost Price Target | Mizuho | Neutral | $89.00 to $104.00 |
| 2014-03-10 | Initiated Coverage | Piper Jaffray | Neutral | |
| 2014-02-10 | Upgrade | Deutsche Bank | Hold to Buy | $95.00 to $98.00 |
| 2014-02-05 | Initiated Coverage | Maxim Group | Buy | $116.00 to $110.00 |
| 2014-01-31 | Upgrade | Bank of America | Neutral to Buy | |
| 2013-12-18 | Initiated Coverage | JMP Securities | Market Perform | |
| 2013-12-11 | Reiterated Rating | Bank of America | Neutral | |
| 2013-12-11 | Reiterated Rating | Citigroup Inc. | Neutral | $101.00 to $93.00 |
| 2013-12-11 | Reiterated Rating | Deutsche Bank | Hold | $110.00 to $95.00 |
| 2013-12-11 | Lower Price Target | Mizuho | Neutral | $98.00 to $89.00 |
| 2013-12-11 | Downgrade | Canaccord Genuity | Buy to Hold | $115.00 to $91.00 |
| 2013-12-04 | Reiterated | UBS | Neutral | $105 to $101 |
| 2013-11-19 | Initiated Coverage | Evercore ISI | Neutral | $110.50 |
| 2013-11-08 | Initiated Coverage | FBR & Co. | Market Perform | $111.00 |
| 2013-10-21 | Boost Price Target | Piper Jaffray | Neutral | $98.00 to $103.00 |
| 2013-10-02 | Boost Price Target | Goldman Sachs | Buy | $91.00 to $98.00 |
| 2013-04-22 | Reiterated | Maxim Group | Buy | $106 to $116 |
| 2013-04-12 | Downgrade | WallachBeth | Buy to Hold | $97 |
| 2012-11-13 | Upgrade | WallachBeth | Hold to Buy | $91 to $97 |
| 2012-10-19 | Reiterated | Mizuho | Neutral | $95 to $93 |
| 2016-06-09 | Reiterated Rating | Credit Suisse | Outperform | $135.00 to $143.00 |
| 2016-06-09 | Reiterated Rating | Credit Suisse Group AG | Outperform | $135.00 to $143.00 |
| 2016-05-22 | Reiterated Rating | KeyBanc | Buy | $143.00 |
| 2016-05-22 | Reiterated Rating | KeyCorp | Buy | $143.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LH 648 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 11.44M |
| Vanguard Group, Inc | 10.62M |
| STATE STREET CORP | 4.18M |
| BlackRock Institutional Trust Company, N.A. | 2.87M |
| WELLINGTON MANAGEMENT CO LLP | 2.77M |
| BlackRock Fund Advisors | 2.61M |
| JPMORGAN CHASE & CO | 2.14M |
| BANK OF AMERICA CORP /DE/ | 1.90M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.84M |
| INSTITUTIONAL CAPITAL LLC | 1.57M |
| DIMENSIONAL FUND ADVISORS LP | 1.48M |
| FMR LLC | 1.23M |
| UBS GLOBAL ASSET MANAGEMENT AMERICAS INC | 1.22M |
| MORGAN STANLEY | 1.10M |
| NORTHERN TRUST CORP | 1.08M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| KING DAVID P President & CEO | 263891.67% (221669) | CAH / LH / |
| BELINGARD JEAN-LUC | 39530.95% (33206) | LH / |
| EBERTS F SAMUEL III Chief Legal Officer, Secretary | 33407.14% (28062) | LH / |
| EISENBERG GLENN A Chief Financial Officer, EVP | 30432.14% (25563) | ANR / ECOL / FDO / LH / TKR / |
| Boyle James T. Jr. EVP, Chief Operating Officer | 27921.43% (23454) | LH / |
| Tanner Deborah L CEO, Covance Drug Development | 23516.67% (19754) | CVD / LH / WST / |
| Hayes William B Chief Financial Officer, EVP | 23095.24% (19400) | LH / PTHN / |
| LANE WENDY E | 22604.76% (18988) | LH / MSCI / WSH / |
| ANDERSON KERRII B | 21541.67% (18095) | ANF / CQB / LH / WOR / |
| MITTELSTAEDT ROBERT E JR | 16870.24% (14171) | ISSC / LH / WPC / |
| WEIKEL M KEITH | 16616.67% (13958) | LH / |
| Rubenstein Arthur H | 14014.29% (11772) | LH / |
| Ratliff John D CEO, Covance Drug Development | 13726.19% (11530) | LH / Q / |
| BERBERIAN LANCE SVP, Chief Information Officer | 13619.05% (11440) | LH / |
| HERRING JOSEPH L CEO of Covance Drug Division | 12385.71% (10404) | CVD / HSIC / LH / TMH / |
| Dodson Edward T Principal Accounting Officer | 10847.62% (9112) | LH / |
| Fonseca Lidia Chief Information Officer | 10817.86% (9087) | GCI / LH / |
| Uthgenannt Lisa J Chief Human Resources Officer | 9826.19% (8254) | LH / |
| Williams R Sanders | 9804.76% (8236) | AMGN / LH / |
| NEUPERT PETER M | 9203.57% (7731) | LH / QSII / |
| Kong Garheng | 7365.48% (6187) | ALIM / CEMP / LH / |
| Schechter Adam H | 7183.33% (6034) | LH / MRK / |
| Brecher Mark E Chief Medical Officer | 6560.71% (5511) | LH / |
| Gilliland Dwight Gary | 5671.43% (4764) | LH / |
| Gary M. Huff CEO, LabCorp Diagnostics | 3833.33% (3220) | LH / |
| Parham Richelle P | 3360.71% (2823) | LH / SNI / |
UM